STOCK TITAN

MP Materials Insider Files Rule 144 to Sell 150,000 Shares Valued $10.8M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MP Materials Corp. notice of a proposed sale under Rule 144 for 150,000 common shares through Fidelity Brokerage Services with an aggregate market value of $10,803,255. The filing lists total shares outstanding as 177,098,314 and an approximate sale date of 08/29/2025 on the NYSE. The shares were acquired as stock awards from the issuer on 03/15/2021 (1,965 shares), 01/14/2022 (3,925 shares), 03/16/2022 (337 shares) and 02/17/2022 (143,773 shares), and payment is shown as compensation. No securities were reported sold in the past three months.

Positive

  • Full Rule 144 disclosure provided including broker, share count, market value, and acquisition details
  • Acquisitions were stock awards received as compensation, clearly listed with dates and amounts
  • No securities sold in the past three months per the filing

Negative

  • Proposed sale of 150,000 shares with aggregate market value of $10,803,255 (approximate sale date 08/29/2025)
  • Insider sale will increase public float by the specified amount when executed

Insights

TL;DR: Insider plans to sell 150,000 shares (~0.085% of outstanding) valued at $10.8M; disclosure is routine under Rule 144.

The filing shows a proposed Rule 144 sale of 150,000 common shares via Fidelity with an aggregate value of $10,803,255 and an approximate sale date of 08/29/2025. Acquisition records indicate the shares were received as stock awards from the issuer and classified as compensation. The filing reports no other sales in the past three months. This is a standard compliance disclosure; the position size relative to outstanding shares is small based on provided figures.

TL;DR: Filing appears procedurally complete: identifies broker, acquisition dates, and compensation basis for awards.

The notice includes broker details, the number of shares proposed for sale, market value, outstanding share count, and acquisition provenance (stock awards from the issuer). The signer attests there is no undisclosed material adverse information. There are no reported sales in the prior three months, and the filing follows Form 144 disclosure elements required for insider sales under Rule 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did MP (MP) disclose in this Form 144 filing?

The filer disclosed a proposed sale of 150,000 common shares via Fidelity with an aggregate market value of $10,803,255, approximate sale date 08/29/2025.

How were the shares being sold by MP acquired?

The shares were acquired as stock awards from the issuer on 03/15/2021 (1,965), 01/14/2022 (3,925), 03/16/2022 (337) and 02/17/2022 (143,773), recorded as compensation.

What broker is handling the proposed sale in the Form 144 for MP?

The filing lists Fidelity Brokerage Services LLC at 245 Summer Street, Boston, MA as the broker.

Does the Form 144 report any securities sold in the past three months for MP?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What does the filer represent about material information in this Form 144?

By signing, the filer represents they do not know of any material adverse information